Power Corp Of Canada Biogen Inc. Transaction History

Power Corp Of Canada

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $1.11 Million - $1.33 Million	-4,977 Reduced 30.85%	11,158 $2.89 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $4.44 Million - $5.13 Million	16,135 New	16,135 $4.6 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $4.44 Million - $5.06 Million	17,312 New	17,312 $4.81 Million
Q3 2022 Nov 18, 2022	BUY	$194.69 - $268.46 $1.65 Million - $2.27 Million	8,458 New	8,458 $2.26 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $1.37 Million - $1.62 Million	7,281 New	7,281 $1.49 Million

1,032

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Power Corp Of Canada, based on Form 13F filings with the SEC.

Stay updated on Power Corp Of Canada with notifications on news.